A new medium-term rat colon bioassay applying neoplastic lesions as endpoints for detection of carcinogenesis modifiers-validation with known modifiers

Cancer Letters

Volumn 232, Issue 2, 2006, Pages 272-278

  Onose, Jun Ichi ^a,b   Imai, Toshio ^a   Hasumura, Mai ^a   Cho, Young Man ^a   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

1,2 Dimethylhydrazine; Bioassay; Colon; Dextran sodium sulfate; Rat

Indexed keywords

1 HYDROXYANTHRAQUINONE; 1,2 DIMETHYLHYDRAZINE; ANTHRAQUINONE DERIVATIVE; CARCINOGEN; DEOXYCHOLIC ACID; DEXTRAN; DRINKING WATER; LACTOFERRIN; NIMESULIDE; SODIUM SULFATE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CARCINOGENESIS; COLON INJURY; CONTROLLED STUDY; DIET; MALE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RAT; VALIDATION PROCESS;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTHRAQUINONES; CARCINOGENICITY TESTS; COLORECTAL NEOPLASMS; DEOXYCHOLIC ACID; DEXTRAN SULFATE; LACTOFERRIN; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 31644449930     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.02.044     Document Type: Article

References (35)

1. T. Tanaka, H. Makita, K. Kawabata, H. Mori, M. Kakumoto, and K. Satoh Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin Carcinogenesis 18 1997 957 965
2. M. Futakuchi, M. Hirose, K. Imaida, S. Takahashi, K. Ogawa, and M. Asamoto Chemoprevention of 2-amino-1-methyl-6-phenylimidazo-[4,5-b] pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats Carcinogenesis 23 2002 283 287
3. N. Ito, K. Imaida, M. Hirose, and T. Shirai Medium-term bioassays for carcinogenicity of chemical mixtures Environ. Health. Perspect. 106 Suppl. 6 1998 1331 1336
4. C.E. Dean Jr., S.A. Benjamin, L.S. Chubb, J.D. Tessari, and T.J. Keefe Nonadditive hepatic tumor promoting effects by a mixture of two structurally different polychlorinated biphenyls in female rat livers Toxicol. Sci. 66 2002 54 61
5. M. Tsutsumi, O. Noguchi, S. Okita, K. Horiguchi, E. Kobayashi, and K. Tamura Inhibitory effects of sulfation inhibitors on initiation of pancreatic ductal carcinogenesis by N-nitrosobis(2-oxopropyl)amine in hamsters Carcinogenesis 16 1995 457 459
6. T. Umemura, K. Sai, A. Takagi, R. Hasegawa, and Y. Kurokawa A possible role for oxidative stress in potassium bromate (KBrO3) carcinogenesis Carcinogenesis 16 1995 593 597
7. K. Okazaki, M. Yamagishi, H.Y. Son, T. Imazawa, F. Furukawa, and H. Nakamura Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4- hydroxybutyl)nitrosamine Nutr. Cancer 42 2002 211 216
8. C. Masuda, H. Wanibuchi, K. Sekine, Y. Yano, S. Otani, and T. Kishimoto Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis Jpn. J. Cancer Res. 91 2000 582 588
9. J.L. Cheng, M. Futakuchi, K. Ogawa, T. Iwata, M. Kasai, and S. Tokudome Dose response study of conjugated fatty acid derived from safflower oil on mammary and colon carcinogenesis pretreated with 7,12-dimethylbenz[a]anthracene (DMBA) and 1,2-dimethylhydrazine (DMH) in female Sprague-Dawley rats Cancer Lett. 196 2003 161 168
10. P. Kubatka, I. Ahlers, E. Ahlersova, E. Adamekova, P. Luk, B. Bojkova, and M. Markova Chemoprevention of mammary carcinogenesis in female rats by rofecoxib Cancer Lett. 202 2003 131 136
11. K. Yasuhara, T. Koujitani, K. Takegawa, M. Nasu, H. Onodera, and H. Takagi Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action Carcinogenesis 22 2001 613 618
12. T. Imai, J. Onose, M. Hasumura, M. Ueda, T. Takizawa, and M. Hirose Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation Toxicol. Pathol. 32 2004 229 236
13. R. Bird Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings Cancer Lett. 37 1987 147 151
14. R. Bird Role of aberrant crypt foci in understanding the pathogenesis of colon cancer Cancer Lett. 93 1995 55 71
15. H. Kohno, T. Tanaka, K. Kawabata, Y. Hirose, S. Sugie, H. Tsuda, and H. Mori Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats Int. J. Cancer 101 2002 461 468
16. I. Thorup, O. Meyer, and E. Kristiansen Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumor incidence in Wistar rats Nutr. Cancer 21 1994 177 182
17. Y. Yamada, N. Yoshimi, Y. Hirose, K. Kawabata, K. Matsunaga, and M. Shimizu Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis Cancer Res. 60 2000 3323 3327
18. M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, and T. Sugimura Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Am. J. Pathol. 163 2003 1607 1614
19. Y. Hirose, T. Kuno, Y. Yamada, K. Sakata, M. Katayama, and K. Yoshida Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis Carcinogenesis 24 2003 107 111
20. J. Onose, T. Imai, M. Hasumura, M. Ueda, and M. Hirose Rapid induction of colorectal tumors in rats initiated with 1,2-dimethylhydrazine followed by dextran sodium sulfate treatment Cancer Lett. 198 2003 145 152
21. I. Okayasu, M. Yamada, T. Mikami, T. Yoshida, J. Kanno, and T. Ohkusa Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model J. Gastroenterol. Hepatol. 17 2002 1078 1083
22. I. Hirono, K. Kuhara, S. Hosaka, S. Tomizawa, and L. Golberg Induction of intestinal tumors in rats by dextran sulfate sodium J. Natl Cancer Inst. 66 1981 579 583
23. T. Iwanaga, O. Hoshi, H. Han, and T. Fujita Morphological analysis of acute ulcerative colitis experimentally induced by dextran sulfate sodium in the guinea pig: some possible mechanisms of cecal ulceration J. Gastroenterol. 29 1994 430 438
24. L.O. Whiteley, L. Hudson Jr., and T.P. Pretlow Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen Toxicol. Pathol. 24 1996 681 689
25. M. Fukutake, S. Nakatsugi, T. Isoi, M. Takahashi, T. Ohta, and S. Mamiya Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice Carcinogenesis 19 1998 1939 1942
26. M. Takahashi, M. Fukutake, S. Yokota, K. Ishida, K. Wakabayashi, and T. Sugimura Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2 J. Cancer Res. Clin. Oncol. 122 1996 219 222
27. K. Sekine, E. Watanabe, J. Nakamura, N. Takasuka, D.J. Kim, and M. Asamoto Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats Jpn. J. Cancer Res. 88 1997 523 526
28. H. Tsuda, K. Sekine, J. Nakamura, Y. Ushida, T. Kuhara, and N. Takasuka Inhibition of azoxymethane initiated colon tumor and aberrant crypt foci development by bovine lactoferrin administration in F344 rats Adv. Exp. Med. Biol. 443 1998 273 284
29. H. Narahara, M. Tatsuta, H. Iishi, M. Baba, N. Uedo, and N. Sakai K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid Int. J. Cancer 88 2000 157 161
30. H. Mori, N. Yoshimi, H. Iwata, Y. Mori, A. Hara, T. Tanaka, and K. Kawai Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: induction of large bowel, liver and stomach neoplasms Carcinogenesis 11 1990 799 802
31. K. Sekine, Y. Ushida, T. Kuhara, M. Iigo, H. Baba-Toriyama, and M.A. Moore Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane Cancer Lett. 121 1997 211 216
32. P.K. Baijal, D.W. Fitzpatrick, and R.P. Bird Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis Nutr. Cancer 31 1998 81 89
33. Y. Zheng, P.M. Kramer, R.A. Lubet, V.E. Steele, G.J. Kelloff, and M.A. Pereira Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci Carcinogenesis 20 1990 255 260
34. D. Guo, H.A. Schut, C.D. Davis, E.G. Snyderwine, G.S. Bailey, and R.H. Dashwood Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat Carcinogenesis 16 1995 2931 2937
35. A.M. Molck, O. Meyer, E. Kristiansen, and I. Thorup IQ (2-amino-3-methylimidazo[4,5-f]quinoline)-induced aberrant crypt foci and colorectal tumour development in rats fed two different carbohydrate diets Eur. J. Cancer Prev. 10 2001 501 506